首页> 外文期刊>Brain pathology >Analysis of the Repressor Element-1 Silencing Transcription Factor/Neuron-Restrictive Silencer Factor Occupancy of Non-Neuronal Genes in Peripheral Lymphocytes from Patients with Huntington's Disease
【24h】

Analysis of the Repressor Element-1 Silencing Transcription Factor/Neuron-Restrictive Silencer Factor Occupancy of Non-Neuronal Genes in Peripheral Lymphocytes from Patients with Huntington's Disease

机译:亨廷顿病患者外周血淋巴细胞中非神经元基因阻遏因子-1沉默转录因子/神经元限制性沉默因子的占有率分析

获取原文
获取原文并翻译 | 示例
       

摘要

We have previously demonstrated that the transcription of neuronal repressor element-1/ neuron-restrictive silencer element (RE1/NRSE)-regulated genes is reduced in the brain of subjects with Huntington's disease (HD) as a result of increased binding of the repressor element-1 silencing transcription factoreuron-restrictive silencer factor (REST/NRSF) to its RE1/NRSE targets. As specific non-neuronal REST/NRSF-regulated genes have been identified in the human genome, we exploited the possibility that the binding of REST/ NRSF to its target RE1/NRSE sites may also be altered in the peripheral tissues of HD patients. Our results show that REST/NRSF occupancy is increased in lymphocytes from HD subjects, thus indicating for the first time that the activity of the RE1/NRSE sites is dysfunctional in vivo. Chromatin immunoprecipitation (ChIP) of the RE1/NRSE sites in lymphocytes may therefore be a reproducible, sensitive and specific means of searching for candidate markers of HD onset and progression.
机译:先前我们已经证明,亨廷顿氏病(HD)受试者大脑中神经元阻遏因子-1 /神经元限制性沉默子(RE1 / NRSE)调控基因的转录由于阻遏因子结合增加而降低-1将转录因子/神经元限制性沉默子因子(REST / NRSF)沉默至其RE1 / NRSE目标。由于已在人类基因组中鉴定出特定的非神经元REST / NRSF调控基因,因此我们探讨了HD患者外周组织中REST / NRSF与其靶RE1 / NRSE位点的结合也可能发生改变的可能性。我们的结果表明,来自HD受试者的淋巴细胞中REST / NRSF的占有率增加,从而首次表明RE1 / NRSE位点的活性在体内是功能失调的。因此,淋巴细胞中RE1 / NRSE位点的染色质免疫沉淀(ChIP)可能是搜索HD发病和进展的候选标记的可重复,敏感和特异的手段。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号